Letter to the editor regarding “TGM6 variants in Parkinson's disease: clinical findings and functional evidence”

• Ashley Hall,
• John P. Quinn,
• Kimberley J. Billingsley,
• on behalf of the International Parkinson's Disease Genomics Consortium (IPDGC)

Affiliations

Ashley Hall

Neurobiology Research Group, Molecular and Clinical Pharmacology, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, L69 3BX, Liverpool, United Kingdom

John P. Quinn

Neurobiology Research Group, Molecular and Clinical Pharmacology, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, L69 3BX, Liverpool, United Kingdom

Kimberley J. Billingsley

Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, 20892, MD, USA

on behalf of the International Parkinson's Disease Genomics Consortium (IPDGC)